ORCID Mandate Trial at Springer Nature

« (…) To further support the uptake of ORCID, in 2017 Springer Nature engaged in a trial mandating ORCID identifiers for corresponding authors of primary research manuscripts at 46 journals across our portfolios.

The trial ran from April 27 for 6 months and the mandate was applied at different stages of the manuscript processing: 14 Nature-branded research journals required iDs at acceptance, while 10 BioMed Central (BMC) and 22 Springer journals did so at initial submission. Corresponding authors were able to share their ORCID identifier in the manuscript tracking system (via the ORCID API); without this step the submission would not proceed to the next stage. (…) »